- Limited operating history, making it difficult to evaluate current business and predict future performance.
- Substantial competition and rapid market changes.
- Extensive government regulations in the medical device industry.
- Potential product liability claims.
- Limited number of suppliers, potentially impacting stable supply of raw materials.
- Need for additional financing to fund operations.
- Historically received government grants for R&D, but future receipt is uncertain.
CRYOFOCUS MEDTECH (SHANGHAI) CO., LTD.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, CRYOFOCUS MEDTECH (SHANGHAI) CO., LTD. disclosed greenhouse gas emissions of 798.23 tCO2e. By scope: Scope 1: 29.29 tCO2e; Scope 2: 3.8K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
798.23 tCO2e
2023
Water Usage
7.5K m3
2023
Waste
16.69 tons
2023
Energy Use
1.4K MWh
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 29.29 tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 3.8K tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 798.23 tCO2e |
| 2022 | 1.0K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Achieved a 22% year-on-year decrease in electricity consumption compared to 2022.
🌱 ESG Focus Areas
Corporate GovernanceProduct ResponsibilitySupply Chain ManagementGreen OperationPeople-Oriented ConceptCommunity Contributions